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Abstract Here we evaluated the effect of leptin on glucose-
induced insulin secretion by normal rat pancreatic islets. We 
show in perifusion experiments that leptin had no acute effect on 
the secretory activity of ß-cells. However, following preexposure 
to leptin a pronounced time- and dose-dependent inhibition of 
both first and second phases of secretion was observed. 
Maximum inhibition was obtained at 24 h and with 100 nM 
leptin. This inhibition did not involve a decrease in cellular insulin 
content. It was also not observed with islets from fa/fa rats. 
Leptin thus inhibits insulin secretion by a mechanism which 
requires long-term preexposure to the hormone and which may 
involve alteration in ß-cell gene expression. 
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1. Introduction 
The obese (ob) gene product encodes a 16 kd protein, re-
ferred to as leptin, which is secreted by adipose tissue [1]. Its 
expression is under the positive control of different hormones 
and neurotransmitters such as epinephrine, glucocorticoids [2] 
and insulin [3]. Leptin is a major hormone controlling food 
intake and energy expenditure and its site of action is thought 
to be mainly in the hypothalamus [4]. Mutation of leptin gene 
in ob/ob mice leads to severe obesity and non-insulin-depend-
ent diabetes mellitus (NIDDM). The receptor for leptin (Ob-
R) is a single transmembrane protein closely related to the 
gpl30 signal-transduction component of cytokine receptor 
[5]. This receptor has several spliced isoforms (a-e) [6]. The 
longer one (Ob-Rb), through its extended cytoplasmic tail, 
transmits intracellular signals, probably through the activa-
tion of the Jack/STAT pathway [7]. This receptor is expressed 
principally in the brain but also in peripheral tissues including 
pancreatic islets [8]. Mutations of this receptor in db/db mice 
[6] or in fa/fa rats [9] are responsible for the development of 
obesity in these animals. 
That leptin is a satiety factor was demonstrated by intra-
peritoneal or intracerebroventricular injections of recombi-
nant hormone to ob/ob mice [10,11] or to normal or fa/fa 
rats [12]. These injections led to reduced food intake, de-
creases in body weight and were correlated with lower plasma 
insulin levels. The decrease in circulating insulin was however 
more pronounced in leptin-treated compared to pair-fed ob/ 
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ob mice showing identical decreases in body weight [13]. This 
last finding and the presence of the long form leptin receptor 
on ß-cells [8] suggested that leptin can play a direct role on the 
control of insulin secretion. The hypothesis of a direct action 
of leptin on the control of insulin secretion has also been 
tested using islets from ob/ob mice. In one report, the secre-
tory response to glucose was markedly reduced [14] and in 
another, the activity of the ATP-dependent K+ channel was 
reported to be increased [15], providing a possible explanation 
for the reduction in secretory activity. Although one report 
mentions that leptin can induce a similar decrease in secretory 
activity in normal pancreatic islets compared to islets from ob/ 
ob mice [14], no such effect could be seen when the secretory 
activity of ß-cells was measured in a pancreas perfusión ex-
periment [16]. At present it is thus not clear whether leptin has 
a real inhibitory effect on insulin secretion by normal islets. 
Other actions on peripheral tissue have been reported. For 
instance leptin has been shown to inhibit cortisol secretion 
from freshly isolated adrenocortical cells [17]. 
In this report, we determined that long-term, but not acute, 
exposure of isolated rat islets to leptin produces a time- and 
dose-dependent inhibition of glucose-induced insulin secre-
tion. This effect was not accompanied by a decrease in islet 
insulin content. This inhibition was also not observed with 
islets isolated from fa/fa rats. These data demonstrate an im-
portant role of leptin on long-term modulation of insulin se-
cretion. Since insulin stimulates leptin secretion, these data 
indicate the presence of an inhibitory control mechanism by 
which leptin negatively modulates insulin secretion. 
2. Material and methods 
2.1. Materials 
Male Sprague-Dawley rats were purchased from Biological Re-
search Laboratories Ltd.; fa/fa rats from IFFA Credo, France; Ficoll 
Dl-400 from Fluka, collagenase (type IV) from Worthington, murine 
leptin (GF050) from Chemicon, and bovine serum albumin (BSA, 
fraction IV RIA grade) from Sigma, antibodies for the insulin radio-
immunoassay from Lineo Research Inc. 
2.2. Islet isolation 
Sprague-Dawley rats were killed, their bile duct cannulated with a 
21-gauge needle, and the pancreas was distended with a solution con-
taining 2 mg/ml collagenase. Each pancreas then was incubated in 
tissue culture flask at 37°C and the islets isolated by the method of 
Gotoh et al. [18]. 
2.3. Islet culture 
After isolation, islets were maintained at 15-20 islets/ml in RPMI 
1640 medium (11 mM glucose), supplemented with 10% fetal calf 
serum, 10 mM HEPES, pH 7.4, 1 mM sodium pyruvate. After one 
day the medium was changed to RPMI containing 5.6 mM glucose 
and the same addition as above, in the absence or presence of different 
concentrations of leptin. 
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2.4. Islets perifusion 
Batches of 10 islets were placed in a perifusion chamber. The peri-
fusion buffer was a Krebs-Ringer solution containing 0.5% BSA, and 
the flow rate was adjusted at 1 ml/min. Perifusion experiments con-
sisted in a 35 min equilibration period in the presence of 2.8 mM 
glucose, a 20 min perifusion in the presence of 16.7 mM glucose, 
and a 15 min perifusion in the presence of 2.8 mM glucose. Fractions 
were collected every minute. Insulin was then quantitated by radio-
immunoassay using rat insulin as a standard. 
2.5. Quantitative analysis 
Results are presented as mean ± S.E.M. Statistical differences were 
analysed by Student's t test. 
0.18 
0.16 
0.14 
0.12 
0.10 H 
0.08 
0.06 -
0.04 
0.02 
B 
0.30 -
0.25 -
3 0.15 H 
^ 0.10 o 
0.05 
0.00 
I 2.8mM 
16.7mM 
2.8mM I 
Control 
ΙΟηΜ Leptin 
10 
I Γ 
20 30 
Time (min) 
40 
2.8mM 
16.7mM 
2.8mM 
Control 
lOOnM leptin 
10 
T 
20 30 
Time (min) 
40 
3. Results 
In a first attempt at evaluating the effect of leptin on insulin 
secretion, rat islets were perifused in the presence or absence 
of different concentrations of leptin. No significant effect on 
the secretory pattern could be observed, even in the presence 
of 100 nM leptin (not shown). We thus evaluated whether 
preexposure of islets to leptin for 24 h would lead to a 
more pronounced inhibitory effect. As shown in Fig. 1, keep-
ing the islets for 24 h in the presence of 10 or 100 nM leptin, 
led to a significant decrease in first and second phases of 
insulin secretion, even though leptin was not present during 
the perifusion experiment. As summarized in Fig. 1C, the 
inhibitory effect was dose-dependent with a maximum inhib-
ition of first and second phase by 43 ± 8% and 44 ± 10%, re-
spectively, obtained with 100 nM leptin. The time-dependence 
of this effect is shown in Fig. 2. A significant decrease in first 
(16 ±0.3%), but not second, phase insulin secretion was al-
ready observed after 6 h of exposure to 100 nM leptin. This 
effect was maximal at 24 h and was not further increased after 
a 48 h incubation period (not shown). 
The insulin content of leptin-treated islets was not signifi-
cantly different from control islets (77.4 ±8.3 ng/islet vs. 
64.4 ±3.4 ng/islet in the presence and absence of leptin, re-
spectively; P>0.3) . Insulin mRNA levels were also un-
changed (not shown). 
Finally, to determine whether the leptin effect was depend-
ent on the presence of a fully active leptin receptor, we eval-
uated the secretory response of islets from fa/fa rats preincu-
bated for 24 h in the presence or absence of 100 nM leptin. 
Fig. 3 shows that leptin did not modify the islet secretory 
response of these islets. 
4. Discussion 
Previous studies have described acute effects of leptin on 
inhibition of insulin release [14] or on activation of the 
ATP-sensitive K+ channels, a key link between glucose me-
tabolism, membrane depolarization and insulin secretion [15]. 
These effects were however obtained with islets obtained from 
ob/ob mice which may have an hypersensitive leptin receptor 
because they have never been previously exposed to the hor-
mone owing to the absence of active leptin in these mice. No 
acute effects of leptin on insulin secretion by perfused pan-
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Fig. 1. Leptin inhibition of glucose-induced insulin secretion. A: 
Rat islets were maintained in the presence or absence of 10 nM lep-
tin for 24 h before the perifusion experiment. Groups of ten islets 
were then hand picked and their secretory response to glucose eval-
uated in perifusion experiments in the presence of the indicated con-
centrations of glucose. Insulin content of the ten control islets was 
0.845 μg and 0.755 μg for the leptin-treated islets. Leptin was ab-
sent from the perifusion experiment. This is a representative experi-
ment out of a total of three. B: Same as in A but with islets pre-
treated with 100 nM leptin. Insulin content of the ten control islets 
was 0.603 μg and 0.679 μg for the leptin-treated islets. C: Quantita-
tion (area under the curve, AUC) of first and second phase insulin 
secretion by islet treated or not with the indicated concentrations of 
leptin. The results are expressed as mean ± S.E.M. for « = 3. The ef-
fect of 1 nM leptin was not significant. 10 nM leptin reduced first 
and second phase secretion by 15 + 2% and 25 ±10%, respectively. 
In the presence of 100 nM leptin, first phase was reduced by 
43 ± 8% and second phase by 44 ± 10%. 
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creas of normal rats were however observed using leptin at a 
dose of 1 nM [16]. 
In the present study we demonstrate that leptin has a pro-
found time- and dose-dependent inhibitory effect on insulin 
secretion. A minimum of 6 h exposure to the hormone is 
required for a significant effect on first phase secretion to be 
observed and a maximal effect on both first and second phases 
is observed at 24 h. The fact that prolonged exposure to leptin 
is required for the inhibitory effect to be observed suggests 
that inhibition is not the result of a direct interaction between 
the intracellular leptin and glucose signalling pathways but, 
rather, that the leptin effect is mediated through a change in 
ß-cell gene expression. These results are thus different from 
those obtained with islets from ob/ob mice which showed an 
acute inhibitory effect on insulin secretion. The bases for this 
difference is not known but may result from the fact that ob/ 
ob islets are hypersensitive to the action of leptin having never 
been exposed previously to the action of this hormone. Alter-
natively a species-specific difference in sensitivity to leptin may 
also be possible. In support of a long-term effect of leptin 
mediated by changes in gene expression are the studies by 
Unger et al. which demonstrated that leptin reduces the ester-
ification and increases the oxidation of fatty acids [19]. The 
increase in fatty acid oxidation can be attributed, at least in 
part, to an increase in the expression of carnitine palmitoyl-
transferase and acetyl CoA oxidase, and to a decrease in the 
expression of acetyl CoA carboxylase [20]. As it has been 
described that elevated levels of free fatty acid inhibit insulin 
secretion by a mechanism dependent on their mitochondrial 
oxidation [21], the above data suggest that the inhibitory ef-
fect of leptin may be mediated by its stimulation of fatty acid 
catabolism. Alternatively, leptin may modify the expression of 
other genes whose products may be essential in different steps 
of the glucose signalling mechanism and of insulin granule 
exocytosis. 
The effect of leptin is concentration-dependent and has been 
observed in the presence of 10 and 100 nM. That these con-
centrations are supraphysiological may indicate that leptin is 
not very stable in in vitro culture over the time course of our 
experiments and since the effect requires a long treatment 
period, high concentrations must be used to observe the in-
hibitory effect. That leptin has no effect on the secretory ac-
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Fig. 2. The effect of recombinant leptin is time-dependent. Islets 
were incubated in absence or presence of 100 nM leptin for 6 and 
24 h before the perifusion experiment was carried out as in Fig. 1. 
Data are expressed as mean ± S.E.M. for n = 3. Data for 24 h time 
point are the same as in Fig. 1. A 6 h incubation led to a decrease 
in first phase (16 ±0.3%) but not in second phase of secretion. 
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Fig. 3. Leptin does not affect the glucose-induced insulin secretion 
by fa/fa rat isolated islets. Islets from fa/fa rats were kept in culture 
for 24 h in the presence of 100 nM leptin. The perifusion experi-
ment was then carried out as in Fig. 1. Insulin content of the ten 
untreated fa/fa islets was 1.25 μg and 1.31 μg for the leptin-treated 
fa/fa islets. This perifusion is representative of two experiments. No 
significant effect of leptin on insulin secretion could be observed. 
tivity of fa/fa rat islets, which have a non-functional receptor, 
strongly argues in favor of a hormone-specific effect. 
Our present demonstration of a pronounced chronic effect 
of leptin on reducing glucose-stimulated insulin secretion sug-
gests the existence of a feedback inhibitory loop regulating 
leptin and insulin secretion. Leptin secretion by adipocytes 
has been shown to be increased by insulin [3]. Our present 
data show that leptin can reduce glucose-induced insulin se-
cretion, thereby providing a feedback inhibitory mechanism to 
lower its own secretion. By which exact mechanism leptin 
inhibits insulin secretion is not yet known. Although altera-
tion in lipid metabolism may be a cause for the secretory 
impairment, modification of other genes involved in glucose 
metabolism, plasma membrane electrical activity, or fusion of 
secretory granules with the plasma membrane may also be 
involved. Also, elucidation of the function of this inhibitory 
feedback mechanism in normal physiology and its possible 
alteration in, for instance, obese hyperinsulinemic patients 
who are known to be hyperleptinemic, should be an important 
goal of future studies. 
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